Published on 10/03/2010
Early treatment of diabetes is important for the long-term management of symptoms, according to a new report.
Research published in the journal Diabetes Care found that the sooner the drug metformin a recommended treatment for type-2 diabetes - is taken to treat the condition, the longer it will remain effective without the need for additional medicines.
Lead author of the study Dr Jonathan Brown confirmed that maximum benefit from the medication is relative to its duration and stages of use.
He said: "We believe that starting the drug early preserves the body's own ability to control blood sugar, which in turn prevents the long-term complications of diabetes like heart disease, kidney failure, and blindness."
Type-2 diabetes develops when the body is unable to produce enough insulin. It normally affects adults above the age of 40, but is becoming increasingly common among younger South Asian people.
A healthy diet and regular exercise is essential to reducing the risk of developing diabetes.
© ActiveQuote Health Ltd. 2010
Categories: Medical
Related Health Insurance News Articles
31/01/2012Prostate cancer discovered in 2,200 year old mummy Prostate cancer has been discovered in the body of a 2,200 year old mummy, indicating that the disease was caused by genetics, not the environment. Researchers studied the unnamed Ptolemaic mummy, which is...
02/02/2012Prostate cancer drug Abiraterone turned down by NICE, but available for patients with private medical coverAbiraterone, a drug that extends the life of prostate cancer sufferers, has been provisionally rejected for use on the NHS. However, it will still be available to patients with private medical insurance . ...
02/02/2012USA300, deadly strain of superbug MRSA, increasing in the UKPotentially deadly strains of MRSA that can be passed between people outside of hospitals are increasing in the UK, warn experts. In a new research paper published in the Journal of Infectious Diseases,...
02/02/2012'Promising' breast cancer vaccine uses immune system to fight the diseaseA vaccine to treat breast cancer using a patient’s own cells has been developed by scientists, with promising results. Researchers at the University of Pennsylvania looked at 27 patients suffering from a...
03/02/2012Bupa, AXA PPP, WPA and Aviva will cover prostate cancer drug AbirateroneAfter we previously reported that prostate cancer drug abiraterone has been deemed by NICE as too expensive for use on the NHS, health insurers are now coming forward to offer cover for the drug. NICE had...